Literature DB >> 12046997

The development of clinical guidelines on paracentesis for ascites related to malignancy.

J Stephenson1, J Gilbert.   

Abstract

Malignancy-related ascites gives rise to troublesome symptoms and carries a poor prognosis. Abdominal paracentesis is a widely used and effective procedure for symptom relief, but practice with regard to the procedure itself may vary considerably. Evidence obtained in the context of liver disease probably influences practice in malignancy, although the pathophysiology involved is different. Anecdotal evidence suggested a difference in practice between the Exeter and District Hospice and the adjoining hospital, and this was confirmed by a review of case notes. Patients undergoing paracentesis in the hospital were more likely to have prior ultrasound assessment and to be given intravenous fluids, and had longer drainage times and longer inpatient stays. It seemed that some practices were placing unnecessary burdens on patients whose life expectancy was short. A set of clinical guidelines for the procedure was drawn up, based on the limited evidence available and the practice within the hospice. These guidelines emphasise performing ultrasound investigations only in cases of diagnostic uncertainty, allowing up to 5 L of fluid to drain without clamping, leaving drains in for no more than 6 h and giving intravenous fluids only when specifically indicated. These guidelines were introduced on the oncology ward of the adjoining hospital. The impact on practice was assessed by means of a retrospective case note review of all procedures carried out on the ward in the 6 months before and after the guidelines were introduced. The introduction of guidelines resulted in significant reductions in prior ultrasound assessment, mean length of time drains were left in and mean length of inpatient stay for planned procedures. There were no cases of symptomatic hypotension in the postguidelines group.

Entities:  

Mesh:

Year:  2002        PMID: 12046997     DOI: 10.1191/0269216302pm509oa

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  9 in total

Review 1.  Symptom management in metastatic breast cancer.

Authors:  William Irvin; Hyman B Muss; Deborah K Mayer
Journal:  Oncologist       Date:  2011-08-31

2.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

Review 3.  Management of drainage for malignant ascites in gynaecological cancer.

Authors:  Alison Keen; Debbie Fitzgerald; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

4.  Peritoneal catheter for continuous drainage of ascites in advanced cancer patients.

Authors:  Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Ferrera; Patrizia Villari; Fabrizio David
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

5.  Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.

Authors:  Christian Martin Kurbacher; Olympia Horn; Jutta Anna Kurbacher; Susanne Herz; Ann Tabea Kurbacher; Ralf Hildenbrand; Reinhardt Bollmann
Journal:  Oncologist       Date:  2015-09-28

6.  Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer.

Authors:  V Harding; E Fenu; H Medani; R Shaboodien; S Ngan; H K Li; R Burt; N Diamantis; M Tuthill; S Blagden; H Gabra; C E Urch; S Moser; R Agarwal
Journal:  Br J Cancer       Date:  2012-08-09       Impact factor: 7.640

7.  Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.

Authors:  Xiaoli Gu; Yuanyuan Zhang; Menglei Cheng; Minghui Liu; Zhe Zhang; Wenwu Cheng
Journal:  BMC Palliat Care       Date:  2016-04-21       Impact factor: 3.234

Review 8.  Symptom Management in Pancreatic Cancer.

Authors:  Kristina G Lee; Varun Roy; Meghan Laszlo; Katelyn M Atkins; Katrina J Lin; Shant Tomassian; Andrew E Hendifar
Journal:  Curr Treat Options Oncol       Date:  2021-01-02

Review 9.  Management of ascites due to gastrointestinal malignancy.

Authors:  Muhammad W Saif; Imran A P Siddiqui; Muhammad A Sohail
Journal:  Ann Saudi Med       Date:  2009 Sep-Oct       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.